Holen Sie sich die Stockscreener-App
35.32
2.14%
0.74
Handel nachbörslich:
35.32
Schlusskurs vom Vortag:
$34.58
Offen:
$34.76
24-Stunden-Volumen:
390.48K
Relative Volume:
0.79
Marktkapitalisierung:
$1.14B
Einnahmen:
$780.57M
Nettoeinkommen (Verlust:
$62.87M
KGV:
20.57
EPS:
1.7171
Netto-Cashflow:
$327.58M
1W Leistung:
+7.65%
1M Leistung:
+9.32%
6M Leistung:
-1.48%
1J Leistung:
+27.14%
1-Tages-Spanne:
$34.33
$35.50
1-Wochen-Bereich:
$32.40
$35.50
52-Wochen-Spanne:
$26.72
$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Firmenname
Collegium Pharmaceutical Inc
Sektor
Telefon
781-713-3699
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Compare COLL vs TAK, ZTS, TEVA, HLN, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
35.32 | 1.12B | 780.57M | 62.87M | 327.58M | 1.7171 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-01-10 | Hochstufung | Needham | Hold → Buy |
| 2024-07-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-05-10 | Herabstufung | Needham | Buy → Hold |
| 2024-05-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-25 | Bestätigt | Needham | Buy |
| 2023-05-02 | Fortgesetzt | Jefferies | Buy |
| 2022-08-08 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-14 | Eingeleitet | BWS Financial | Sell |
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral |
| 2020-02-19 | Fortgesetzt | Jefferies | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-05-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2019-04-12 | Fortgesetzt | Janney | Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2018-02-07 | Bestätigt | Needham | Buy |
| 2017-12-05 | Bestätigt | Needham | Buy |
| 2017-09-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Bestätigt | Needham | Buy |
| 2016-09-13 | Eingeleitet | Gabelli & Co | Buy |
| 2015-06-01 | Eingeleitet | Jefferies | Buy |
| 2015-06-01 | Eingeleitet | Needham | Buy |
| 2015-06-01 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
MSN Money - MSN
Is Collegium Pharmaceutical (COLL) Offering A Valuation Opportunity After Recent Share Price Weakness - Sahm
Understanding the Setup: (COLL) and Scalable Risk - Stock Traders Daily
Collegium Pharmaceutical Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo
Earnings Preview: Collegium Pharmaceutical (COLL) Q1 Earnings Expected to Decline - Yahoo Finance
Collegium Pharmaceutical (COLL) to Release Quarterly Earnings on Thursday - MarketBeat
Collegium Pharmaceutical, Inc. (COLL) hits fresh high: Is there still room to run? - MSN
Q1 EPS Estimate for Collegium Pharmaceutical Cut by Analyst - MarketBeat
Collegium to buy ADHD medicine Azstarys for up to $785M - MSN
Equities Analysts Offer Predictions for COLL Q2 Earnings - MarketBeat
Collegium to Report First Quarter 2026 Financial Results on May 7, 2026 - GlobeNewswire
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Maintains Target Price $44 - Moomoo
Is Collegium Pharmaceutical (COLL) one of the best small-cap drug manufacturers? - MSN
Collegium (COLL) Stock: Worth Buying? (Edges Up) 2026-04-18Company Analysis - Cổng thông tin điện tử tỉnh Lào Cai
Collegium Pharmaceutical stock (US19459E1029): Is its opioid pain management focus strong enough to - AD HOC NEWS
Collegium Pharmaceutical Targets 825 Million Dollars in 2026 Revenue - HarianBasis.co
Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a 64% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Collegium Pharmaceutical Inc (COLL) Stock Down 5.4% -- Now Under - GuruFocus
Collegium Pharmaceutical (NASDAQ:COLL) Stock Price Down 4.6%Here's What Happened - MarketBeat
Truist reiterates Buy on Collegium Pharmaceutical stock By Investing.com - Investing.com Canada
Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $56 - Moomoo
CapEx per share of Collegium Pharmaceutical, Inc. – FWB:354 - TradingView — Track All Markets
Collegium Pharmaceutical Sets 2026 Revenue Outlook, Details $650M AZSTARYS Deal at Needham Conference - MarketBeat
Collegium (COLL) Stock: Investor Confidence (-1.99%) 2026-04-15Gap Down Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Massachusetts Financial Services Co. MA Increases Stock Position in Collegium Pharmaceutical, Inc. $COLL - MarketBeat
Aug Technicals: Does Collegium Pharmaceutical Inc offer margin of safetyGlobal Markets & Daily Chart Pattern Signals - baoquankhu1.vn
Collegium Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Smith Thomas B - Moomoo
How The Collegium Pharmaceutical (COLL) Narrative Is Evolving On A Modest Target Price Shift - Yahoo Finance
Assessing Collegium Pharmaceutical (COLL) Valuation After Mixed Recent Share Price Performance - Sahm
Chipmakers Recap: What is the target price for Collegium Pharmaceutical Inc stockGDP Growth & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Sectors Review: Does Collegium Pharmaceutical Inc offer margin of safetyBreakout Watch & Advanced Technical Signal Analysis - baoquankhu1.vn
COLL SEC FilingsCollegium Pharmaceutical Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Precision Trading with Collegium Pharmaceutical Inc. (COLL) Risk Zones - Stock Traders Daily
Q4 Earnings Highs And Lows: Pfizer (NYSE:PFE) Vs The Rest Of The Branded Pharmaceuticals Stocks - TradingView — Track All Markets
Collegium to Participate in Upcoming Investor Conferences - Bitget
Collegium Pharmaceutical, Inc. (COLL) stock price, news, quote and history - Yahoo Finance UK
Collegium Pharmaceutical, Inc. Files Form 8-K with SEC: Company Details, Stock Information, and Filing Data (April 2, 2026) - Minichart
How Prospective US Tariffs on Branded Drug Imports Will Impact Collegium Pharmaceutical (COLL) Investors - Sahm
Collegium Pharmaceutical, Inc. (COLL) Stock forecasts - Yahoo Finance UK
Inflation Data: What are analysts price targets for Collegium Pharmaceutical Inc2026 Momentum Check & Safe Entry Trade Reports - baoquankhu1.vn
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.67%
2.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):